Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Ong, V. Indumathi, W. Poh, Y. Ong (2000)
The diagnostic yield of pleural fluid cytology in malignant pleural effusions.Singapore medical journal, 41 1
A. Stefani, P. Natali, C. Casali, U. Morandi (2006)
Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 30 6
R. Cohen, R. Cohen, William Shely, W. Shely, Suzanne Thompson, Suzanne Thompson, J. Hagen, J. Hagen, Charles Marboe, Charles Marboe, T. Demeester, T. Demeester, Vaughn Starnes, V. Starnes (1996)
Talc pleurodesis: talc slurry versus thoracoscopic talc insufflation in a porcine model.The Annals of thoracic surgery, 62 4
O. Ishimoto, Y. Saijo, K. Narumi, Y. Kimura, M. Ebina, Nobumichi Matsubara, N. Asou, Y. Nakai, T. Nukiwa (2002)
High Level of Vascular Endothelial Growth Factor in Hemorrhagic Pleural Effusion of CancerOncology, 63
E. Penz, Kristina Watt, Christopher Hergott, N. Rahman, I. Psallidas (2017)
Management of malignant pleural effusion: challenges and solutionsCancer Management and Research, 9
John Heffner (2007)
Diagnosis and management of malignant pleural effusionsRespirology, 13
J. Yates, M. Atay, H. Langeluttig, C. Brasher (1961)
Pleural disease.Medical times, 89
R. Kushwaha, P. Shashikala, S. Hiremath, H. Basavaraj (2008)
Cells in pleural fluid and their value in differential diagnosisJournal of Cytology, 25
T. Laisaar, Veronika Palmiste, T. Vooder, T. Umbleja (2006)
Life expectancy of patients with malignant pleural effusion treated with video-assisted thoracoscopic talc pleurodesis.Interactive cardiovascular and thoracic surgery, 5 3
(2021)
Eur Respir J 25(4): 0903–1936 Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
Soumitra Eachempati (2004)
Sabiston Textbook of SurgerySurgical Infections, 5
G. Khaleeq, A. Musani (2008)
Emerging paradigms in the management of malignant pleural effusions.Respiratory medicine, 102 7
A. Leff, P. Hopewell, J. Costello (1978)
Pleural effusion from malignancy.Annals of internal medicine, 88 4
Kathleen Shuey, Yvette Payne (2005)
Malignant pleural effusion.Clinical journal of oncology nursing, 9 5
D. Feller-Kopman, C. Reddy, M. Decamp, R. Diekemper, M. Gould, T. Henry, N. Iyer, Y. Lee, S. Lewis, N. Maskell, N. Rahman, D. Sterman, M. Wahidi, A. Balekian (2018)
Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice GuidelineAmerican Journal of Respiratory and Critical Care Medicine, 198
A. Leung, N. Müller, R. Miller (1990)
CT in differential diagnosis of diffuse pleural disease.AJR. American journal of roentgenology, 154 3
V. Antony, R. Loddenkemper, P. Astoul, C. Boutin, P. Goldstraw, J. Hott, F. Panadero, S. Sahn (2001)
Management of malignant pleural effusions.The European respiratory journal, 18 2
G. Stathopoulos, I. Kalomenidis (2012)
Malignant pleural effusion: tumor-host interactions unleashed.American journal of respiratory and critical care medicine, 186 6
Neeraj Desai, Hans Lee (2017)
Diagnosis and management of malignant pleural effusions: state of the art in 2017.Journal of thoracic disease, 9 Suppl 10
J. Massarelli (1984)
Harrison's Principles of Internal MedicineJAMA, 251
(1950)
Harrison's Principles of Internal Medicine
(1968)
Malignant pleural effusion.British Medical Journal, 3
B. Ozcakar, C. Martínez, R. Morice, G. Eapen, D. Ost, M. Sarkiss, H. Chiu, C. Jimenez (2010)
Does pleural fluid appearance really matter? The relationship between fluid appearance and cytology, cell counts, and chemical laboratory measurements in pleural effusions of patients with cancerJournal of Cardiothoracic Surgery, 5
M. Tattersall, Michael Boyer (1990)
Management of malignant pleural effusions.Thorax, 45
Tom Syer, David Arnold, A. Edey, Nick Maskell (2010)
P98 Investigation of unilateral pleural effusion: what CT scan should be ordered?Thorax, 74
H. Davies, Y. Lee (2013)
Management of malignant pleural effusions: questions that need answersCurrent Opinion in Pulmonary Medicine, 19
K. Berliner (1941)
HEMORRHAGIC PLEURAL EFFUSION; AN ANALYSIS OF 120 CASES*Annals of Internal Medicine, 14
editor-in-chief M.Thwnsend (2004)
Sabiston Textbook of Surgery
Yongchun Shen, Meng-qi Liu, C. Wan, Lei Chen, Tao Wang, F. Wen (2012)
Diagnostic accuracy of vascular endothelial growth factor for malignant pleural effusion: A meta-analysis.Experimental and therapeutic medicine, 3 6
N. Maskell, R. Butland (2003)
BTS guidelines for the investigation of a unilateral pleural effusion in adults.Thorax, 58 Suppl 2
J. Heffner, J. Klein (2008)
Recent advances in the diagnosis and management of malignant pleural effusions.Mayo Clinic proceedings, 83 2
A. Yim, A. Chan, T. Lee, Innes Wan, J. Ho (1996)
Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion.The Annals of thoracic surgery, 62 6
Hemorrhagic malignant pleural effusion (HMPE) is diagnosed in 47–50% of all malignant pleural effusions (MPE). The aim of this study is to evaluate clinical, radiological, and morphological manifestations of HMPE and results of talc pleurodesis treatment. This is a retrospective review of the medical charts of 135 MPE patients which consists of HMPE group (42 patients) and simple MPE group (63 patients) (median age 67.9 years; 43 males, 62 females). In HMPE vs. simple MPE patients, pronounced dyspnea (100% vs. 88.9%, P = 0.024), chest pain (59.5% vs. 60.3%, P = 1), general deterioration (78.6% vs. 74.6%, P = 0.411) combined with large pleural effusion (81% vs. 50.8%, P = 0.001), and thickening of parietal pleura (73.8% vs. 68.3%, P = 0.349), all were more specific for HMPE.Cytological examination of HMPE showed more malignant pleural fluid cells (81% vs. 63.5%, P = 0.043). Histological examination revealed poorly differentiated types of tumors in 69.05% of HMPE (bronchogenic 33.33%, intestinal 16.67%, breast 14.3%) vs. 7.94% of simple MPE. In 19 HMPE vs. 0 simple MPE patients, thoracoscopy showed bleeding nodules (94.7%) on thickened parietal pleura (84.2%). Pleurodesis with talc by slurry (59%) and poudrage (41%) was less effective in HMPE than in simple MPE patients after 1 month (failed response; 33.3% vs. 21.6, P = 0.019), 3 months (42.9% vs. 25.7%, P = 0.017), and 6 months (42.9% vs. 21.7%, P = 0.035). Survival in HMPE was significantly lower (3.06 months vs. 5.37 months, P = 0.0005). HMPE has more severe clinical, laboratory, radiological, and endoscopic manifestations due to a more poorly differentiated malignant process.Talc pleurodesis was less effective in HMPE, and survival was poor.
"Indian Journal of Surgical Oncology" – Springer Journals
Published: Nov 14, 2020
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.